Kirstin Perdrizet

9PUBLICATIONS
36CO-AUTHORS
Liquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 17, 2026
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2026.3.3.

|Feb 26, 2026
Early Experience with Tarlatamab (T-Cell Engagers) for Extensive-Stage Small Cell Lung Cancer (ES-SCLC) in Canada: Lessons Learned and Implementation Strategies.

Parneet K Cheema, Kirstin A Perdrizet, Randeep S Sangha

|Mar 26, 2025
Toward Timely and Equitable Advanced Biomarker Testing for Patients with Metastatic Cancer in Canada.

Brandon S Sheffield, Shantanu Banerji, Allen Chankowsky

|Jul 27, 2024
Point of Care Liquid Biopsy for Cancer Treatment-Early Experience from a Community Center.

Champica Nicholas, Andrea Beharry, Anna M Bendzsak

|Jul 25, 2022
Upfront Next Generation Sequencing in Non-Small Cell Lung Cancer.

Shelley Kuang, Andrea S Fung, Kirstin A Perdrizet

|Mar 24, 2022
Point of Care Molecular Testing: Community-Based Rapid Next-Generation Sequencing to Support Cancer Care.

Brandon S Sheffield, Andrea Beharry, Joanne Diep

Pageof 2

Frequent Collaborators

2 joint publications

Shaan Dudani

1 joint publications

T B Nguyen

1 joint publications

G O Cron

1 joint publications

K Bezzina